| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,085,293 | 1,597,078 | 1,646,916 | 2,032,182 | | Cost of Revenue |
-
|
-
|
-
| (504,925) | | | Gross Profit |
-
| 1,597,078 | 1,646,916 | 2,537,107 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 318,620 | 315,185 | 301,483 | 869,067 | | Non Recurring | 3,592 | 4,430 | 4,773 | (77,926) | | Others | (144,460) | 627,064 | 366,914 | 586,275 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 650,399 | 973,746 | 1,159,691 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 907,541 | 650,399 | 973,746 | 1,159,691 | | Interest Expense |
-
| 819,459 | 1,026,547 | 1,529,522 | | Income Before Tax | 233,671 | (169,060) | (52,801) | (369,831) | | Income Tax Expense | 74,363 | (46,551) | (31,696) | (154,341) | | Minority Interest | (198) | (492) |
-
| (527) | | | | Net Income From Continuing Ops | 159,110 | (123,001) | (21,105) | (216,017) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 159,110 | (123,001) | (21,105) | (216,017) | | Preferred Stock And Other Adjustments | (42,627) | (25,519) | (26,676) | (27,316) | | | Net Income Applicable To Common Shares | $116,483 | ($148,520) | ($47,781) | ($243,333) |
|
0.29% Nasdaq 
0.21%
Income Statement
